PE20230178A1 - Composiciones enriquecidas de acidos grasos poliinsaturados - Google Patents
Composiciones enriquecidas de acidos grasos poliinsaturadosInfo
- Publication number
- PE20230178A1 PE20230178A1 PE2022000667A PE2022000667A PE20230178A1 PE 20230178 A1 PE20230178 A1 PE 20230178A1 PE 2022000667 A PE2022000667 A PE 2022000667A PE 2022000667 A PE2022000667 A PE 2022000667A PE 20230178 A1 PE20230178 A1 PE 20230178A1
- Authority
- PE
- Peru
- Prior art keywords
- fatty acids
- polyunsaturated fatty
- compositions enriched
- lipid composition
- enriched
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title 1
- 150000002632 lipids Chemical class 0.000 abstract 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- -1 DTAn-3 Chemical compound 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
Abstract
Referido a una composicion lipidica enriquecida de acidos grasos poliinsaturados, omega-3 de cadena larga, con al menos uno de DPAn-3, DTAn-3, ETA o ETrA, opcionalmente con OA o ALA. En donde dicha composicion lipidica es de origen vegetal, esteres etilicos o trigliceridos. Esta composicion presenta estabilidad mejorada, ademas que inhibe la produccion de citocinas inflamatorias. Tambien se refiere a formulas farmaceuticas y su uso en el tratamiento o prevencion de enfermedades cardiovasculares, entre otros.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926239P | 2019-10-25 | 2019-10-25 | |
| PCT/GB2020/052687 WO2021079142A1 (en) | 2019-10-25 | 2020-10-23 | Enriched polyunsaturated fatty acid compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20230178A1 true PE20230178A1 (es) | 2023-02-01 |
Family
ID=73038258
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2022000667A PE20230178A1 (es) | 2019-10-25 | 2020-10-23 | Composiciones enriquecidas de acidos grasos poliinsaturados |
| PE2023002986A PE20250163A1 (es) | 2019-10-25 | 2020-10-23 | Composiciones enriquecidas de acidos grasos poliinsaturados |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2023002986A PE20250163A1 (es) | 2019-10-25 | 2020-10-23 | Composiciones enriquecidas de acidos grasos poliinsaturados |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220362199A1 (es) |
| EP (1) | EP4048252A1 (es) |
| JP (1) | JP2022554152A (es) |
| KR (1) | KR20220088902A (es) |
| CN (1) | CN114867476A (es) |
| AR (2) | AR122331A1 (es) |
| AU (1) | AU2020370081A1 (es) |
| BR (1) | BR112022007695A2 (es) |
| CA (1) | CA3155544A1 (es) |
| CL (1) | CL2023002953A1 (es) |
| CO (1) | CO2022005055A2 (es) |
| MX (2) | MX2022004887A (es) |
| PE (2) | PE20230178A1 (es) |
| WO (1) | WO2021079142A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2529572T3 (es) | 2004-04-22 | 2015-02-23 | Commonwealth Scientific And Industrial Research Organisation | Síntesis de ácidos grasos poliinsaturados de cadena larga por células recombinantes |
| EP2120920A4 (en) * | 2007-02-20 | 2011-06-15 | Martek Biosciences Corp | OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE |
| DK2358882T3 (da) * | 2008-11-18 | 2017-11-06 | Commw Scient Ind Res Org | Enzymer og fremgangsmåder til fremstilling af omega-3 fedtsyrer |
| JP6242882B2 (ja) | 2012-06-15 | 2017-12-06 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション | 植物細胞における長鎖多価不飽和脂肪酸の産生 |
| CN104726473B (zh) | 2013-12-18 | 2020-02-14 | 联邦科学技术研究组织 | 包含二十二碳六烯酸的提取的植物脂质 |
| PH12016502586B1 (en) | 2014-06-27 | 2023-07-19 | Commw Scient Ind Res Org | Lipid comprising docosapentaenoic acid |
| CN109661458B (zh) | 2016-06-16 | 2023-05-09 | 纽希得营养澳大利亚私人有限公司 | 近交转基因油菜品系ns-b50027-4及其种子 |
| NZ749655A (en) | 2016-06-16 | 2023-01-27 | Nuseed Nutritional Australia Pty Ltd | Elite event canola ns-b50027-4 |
-
2020
- 2020-10-23 PE PE2022000667A patent/PE20230178A1/es unknown
- 2020-10-23 WO PCT/GB2020/052687 patent/WO2021079142A1/en active Application Filing
- 2020-10-23 AU AU2020370081A patent/AU2020370081A1/en active Pending
- 2020-10-23 JP JP2022523882A patent/JP2022554152A/ja active Pending
- 2020-10-23 KR KR1020227017412A patent/KR20220088902A/ko active Pending
- 2020-10-23 CN CN202080074278.7A patent/CN114867476A/zh active Pending
- 2020-10-23 MX MX2022004887A patent/MX2022004887A/es unknown
- 2020-10-23 US US17/771,173 patent/US20220362199A1/en active Pending
- 2020-10-23 PE PE2023002986A patent/PE20250163A1/es unknown
- 2020-10-23 AR ARP200102935A patent/AR122331A1/es unknown
- 2020-10-23 CA CA3155544A patent/CA3155544A1/en active Pending
- 2020-10-23 BR BR112022007695A patent/BR112022007695A2/pt unknown
- 2020-10-23 EP EP20799808.9A patent/EP4048252A1/en active Pending
-
2022
- 2022-04-22 CO CONC2022/0005055A patent/CO2022005055A2/es unknown
- 2022-04-22 MX MX2023011681A patent/MX2023011681A/es unknown
-
2023
- 2023-10-02 AR ARP230102632A patent/AR130658A2/es unknown
- 2023-10-03 CL CL2023002953A patent/CL2023002953A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2022004887A (es) | 2022-08-04 |
| JP2022554152A (ja) | 2022-12-28 |
| CO2022005055A2 (es) | 2022-11-29 |
| CL2023002953A1 (es) | 2024-04-12 |
| WO2021079142A1 (en) | 2021-04-29 |
| KR20220088902A (ko) | 2022-06-28 |
| CA3155544A1 (en) | 2021-04-29 |
| AU2020370081A1 (en) | 2022-06-02 |
| MX2023011681A (es) | 2023-10-18 |
| CN114867476A (zh) | 2022-08-05 |
| PE20250163A1 (es) | 2025-01-22 |
| EP4048252A1 (en) | 2022-08-31 |
| US20220362199A1 (en) | 2022-11-17 |
| AR122331A1 (es) | 2022-08-31 |
| TW202128142A (zh) | 2021-08-01 |
| AR130658A2 (es) | 2025-01-08 |
| BR112022007695A2 (pt) | 2022-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX384370B (es) | Lípido que comprende ácidos grasos poliinsaturados de cadena larga. | |
| NZ737380A (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
| CO6341615A2 (es) | Salicilatos acetilados con acidos grasos y sus usos. | |
| CO2021014835A2 (es) | Ácidos grasos poliinsaturados de cadena muy larga, derivados hidroxilados elovanoides y métodos de uso | |
| AR072579A1 (es) | Aceites no- trans funcionales con relacion omega-6 a omega -3 modulada | |
| MX2009009838A (es) | Esteres de acidos grasos de glucocorticoides como agentes antiinflamatorios y anti-cancer. | |
| CO2021000418A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con ala | |
| CL2020002728A1 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| ECSP22047989A (es) | Formulaciones que comprenden un mineral y/o una vitamina y un polisac?rido, composiciones de las mismas y uso de las mismas en la suplementaci?n de dicho mineral y/o vitamina | |
| PE20230178A1 (es) | Composiciones enriquecidas de acidos grasos poliinsaturados | |
| SE0201566D0 (sv) | New composition | |
| CO2021000430A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| CO2021000426A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| CO2021000431A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| WO2016195016A8 (ja) | 新規なトリグリセリド及びその用途 | |
| MY175186A (en) | Glyceride composition | |
| AR044623A1 (es) | Grasa vegetal modificada | |
| EA202092556A1 (ru) | Композиции полиненасыщенных жирных кислот, обогащенные дгк | |
| MX2023006728A (es) | Esteres de acido dicarboxilico para inducir un efecto analgesico. | |
| GB2504427A9 (en) | Green coalescent agent composition containing fatty acid monoesters of vegetable oils with fusel oil alcohols | |
| HN2011000079A (es) | Salicilatos acetilados con acidos grasos y sus usos |